trending Market Intelligence /marketintelligence/en/news-insights/trending/55Wy2h2WaD06WIiXVjCJZw2 content esgSubNav
In This List

Natus Medical closes purchase of Integra LifeSciences assets

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Natus Medical closes purchase of Integra LifeSciences assets

Natus Medical Inc. completed its previously announced acquisition of certain Integra LifeSciences Holdings Corp. neurosurgery assets.

Natus Medical acquired the global Camino ICP monitoring product line including the San Diego manufacturing facility, the U.S. rights relating to Integra's fixed pressure shunts and the U.S. rights to Codman's Duraform dural graft implant, standard EVD catheters and CSF collection systems.